Literature DB >> 12189001

The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System.

Shane Darke1, Libby Topp, Joanne Ross.   

Abstract

Trends in the injection of methadone and benzodiazepines by injecting drug users (IDU) recruited in Sydney for the Illicit Drug Reporting System over the period 1996-2000 were examined. A total of 788 IDU were interviewed over the 5-year period. The proportion of IDU reporting recent methadone injecting declined significantly over the study period, from a peak of 31% in 1997 to 13% in 2000. Unlike the injection of methadone, there was no significant difference between the proportions of IDU reporting recent benzodiazepine injecting over the study period, which ranged between 10% and 16%. A consistent minority (range 5-7%) of IDU reported having injected both methadone and benzodiazepines in all years of the study. There were no differences in the proportions of males and females reporting recent methadone or benzodiazepine injecting in any individual year. Both methadone and benzodiazepine injecting were independently associated with higher levels of injection-related health problems. Given the substantial harms associated with these practices, continued monitoring of their prevalence is warranted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189001     DOI: 10.1080/09595230220119318

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  8 in total

1.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

2.  Characteristics Associated with Nonmedical Methadone Use among People Who Inject Drugs in California.

Authors:  Johnathan K Zhao; Alex H Kral; Lynn D Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2019-10-14       Impact factor: 2.164

3.  Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs.

Authors:  Paxton Bach; Geoffrey Walton; Kanna Hayashi; M-J Milloy; Huiru Dong; Thomas Kerr; Julio Montaner; Evan Wood
Journal:  Am J Public Health       Date:  2016-03-17       Impact factor: 9.308

Review 4.  Health harms of non-medical prescription opioid use: A systematic review.

Authors:  Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall
Journal:  Drug Alcohol Rev       Date:  2022-04-18

5.  Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders.

Authors:  Geetha A Subramaniam; Maxine L Stitzer; George Woody; Marc J Fishman; Ken Kolodner
Journal:  Drug Alcohol Depend       Date:  2008-09-25       Impact factor: 4.492

6.  Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.

Authors:  Shannon Gwin Mitchell; Sharon M Kelly; Barry S Brown; Heather Schacht Reisinger; James A Peterson; Adrienne Ruhf; Michael H Agar; Kevin E O'Grady; Robert P Schwartz
Journal:  Am J Addict       Date:  2009 Sep-Oct

7.  Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study.

Authors:  Li-Tzy Wu; Dan G Blazer; Maxine L Stitzer; Ashwin A Patkar; Jack D Blaine
Journal:  Am J Addict       Date:  2008 Jul-Aug

8.  Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.

Authors:  Björn Johnson; Torkel Richert
Journal:  Harm Reduct J       Date:  2019-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.